INTRODUCTION
============

A variety of biological processes, including cell differentiation and development, involve alternative pre-mRNA splicing. Splicing regulation is essentially governed by regulatory factors that bind to *cis*-elements in regulated exons or flanking introns and/or act through protein--protein interactions ([@B10]; [@B8]). RNA-binding motif protein 4 (RBM4) regulates alternative splicing of pre-mRNAs and is also involved in cell differentiation ([@B18]; [@B20], [@B19]). Mammalian genomes have two copies of *Rbm4*, namely *Rbm4a* and *Rbm4b*. Knockout of either *Rbm4* reduces the size of embryonic pancreatic islets ([@B20]). *Rbm4* knockout results in aberrant splicing patterns of several pancreatic factors and reduction in insulin gene expression in embryonic pancreas ([@B20]). These observations provide in vivo evidence that RBM4 is important for cell differentiation and development via its role in alternative splicing and gene expression.

The nervous system adopts alternative splicing for cell differentiation, morphogenesis, and even synapse formation and plasticity. A number of RNA-binding proteins, such as Nova, Rbfox, nSR100, and polypyrimidine tract-binding protein, are involved in splicing regulation during neuronal cell differentiation ([@B11]; [@B27]; [@B34]). Genetic knockouts and cross-linking/immunoprecipitation/high-throughput sequencing experiments have revealed the details of splicing mechanisms involving these factors, as well as their roles in neural function and development ([@B11]; [@B27]; [@B34]). For example, *Nova2* knockout impairs the splicing isoform switch of Disabled-1 in the developing cerebral cortex and thus disrupts neuronal migration during lamina formation ([@B33]). Nova binds to YCAY nucleotide sequences (Y stands for pyrimidine) near regulated exons, and its binding shows position-dependent effects on splicing regulation ([@B16]; [@B33]). The members of each splicing regulator family may exhibit different anatomical and temporal expression and therefore have different functions in brain. RBM4 has been detected in the cortical plate of embryonic mouse brain during gestation, and its level is reduced in fetal Down syndrome brain ([@B4]), suggesting that RBM4 plays a role in neuronal differentiation and perhaps participates in pathogenesis.

In the present study, we find that *Rbm4* knockout altered exon usage of Numb, a key cell-fate determination factor for neural development ([@B32]). During neurogenesis, *Drosophila* Numb plays a critical role in asymmetric cell division and specifies the fate of sibling neuron cells ([@B32]). Mammalian Numb has multiple functions during neural development, including maintaining neural progenitor cells through symmetric divisions, as well as promoting neuronal differentiation and even coordinating the polarization of migratory neurons ([@B17]; [@B5]). Mammalian Numb genes express mRNA isoforms essentially via differential selection of two alternative exons (exons 3 and 9 in mouse Numb), generating protein isoforms containing different lengths of the phosphotyrosine-binding (PTB) domain and the proline-rich region (PRR) domain ([@B31]). A switch in Numb isoforms is crucial for cortical development ([@B1]). The long PRR (PRR^L^)--containing isoforms promote cell proliferation, whereas the short PRR (PRR^S^)--containing isoforms enhance differentiation in cultured neuronal cells ([@B31]; [@B1]). Numb is involved in Notch signaling, which maintains neuronal progenitor cells and inhibits their differentiation into neurons ([@B21]). In *Drosophila*, Numb promotes neuronal differentiation by antagonizing Notch signaling ([@B30]). Numb-PTB^L^ isoforms negatively regulate Notch1 activity by promoting its ubiquitination and subsequent degradation ([@B25]; [@B24]). Moreover, Numb isoforms function differently in neurite outgrowth and cell death in response to neurotrophic factors and changes in neuronal activity ([@B28]; [@B22]).

Several splicing regulators can modulate Numb exon selection. The neuron-specific splicing factor Rbfox3 represses the inclusion exon 12 (equivalent to rodent exon 9) of chick Numb, resulting in PRR^S^ isoforms that are critical for neuronal differentiation and spinal cord development ([@B15]). Aberrant alternative splicing of Numb is also implicated in tumorigenesis ([@B2]; [@B35]). The RNA-binding protein QKI suppresses exon 12 inclusion of Numb, producing isoforms that inhibit cell proliferation. Down-regulation of QKI-5 in lung cancer promotes tumorigenesis ([@B35]). A similar scenario was observed in another Numb splicing regulator, RBM10, whose mutations in lung cancer also contribute to tumor progression ([@B2]). Because the isoform switch of Numb is important for neuronal development and cancer pathogenesis, it is necessary to understand its underlying mechanism.

Our preliminary observation that *Rbm4* knockout resulted in abnormal Numb isoform ratios in embryonic brain prompted us to characterize the role of RBM4 in regulating Numb splicing and neuronal differentiation via Numb-mediated pathways.

RESULTS
=======

RBM4 expression and the splicing switch of neuronal transcripts during neuronal differentiation
-----------------------------------------------------------------------------------------------

The fact that RBM4 is expressed in mouse embryonic brain ([@B6]) prompted us to assess the role of RBM4 in brain development. However, *Rbm4* single-gene knockout did not exhibit visible defects in brain (unpublished data). We then performed Golgi staining of newborn neurons but did not observe any significant difference in the number of primary dendrites and axonal length between wild-type and knockout mice (Supplemental Figure S1). Nevertheless, we cultured cortical neurons isolated from *Rbm4a*^−*/*−^ embryos. The growth rate of *Rbm4a*-knockout neurites was slightly slower than that of wild type at 1 d in vitro (DIV1) but had no significant difference from the wild type at a later time (DIV3; Supplemental Figure S2). We reasoned that two *Rbm4* genes may functionally compensate for each other.

We then used mouse embryonal carcinoma P19 cells to examine RBM4 expression during neuronal differentiation. We treated the cells with retinoic acid (RA) to form embryoid bodies. After RA treatment, we cultured cells in a neurobasal medium in the presence of a proliferation inhibitor (see *Materials and Methods*). On induction of differentiation, the cells exhibited protruding processes and expressed the neuronal marker MAP2 ([Figure 1](#F1){ref-type="fig"}). Rbm4b mRNA level slightly increased until day 2 and then decreased, whereas Rbm4a abundance was essentially constant ([Figure 1](#F1){ref-type="fig"}). Immunoblotting using anti-RBM4 showed that the level of total RBM4 was transiently up-regulated and also peaked at day 2 ([Figure 1](#F1){ref-type="fig"}).

![The expression pattern of RBM4 and neuronal transcript isoforms during neuronal differentiation of P19 cells. P19 cells (2 × 10^6^) were cultured in the differentiation medium containing 1 μM RA to allow embryoid body formation (undifferentiated; UD). Four days later, 1 × 10^6^ cells were reseeded into a six-well plate, and the media were changed to the neurobasal medium containing B27 supplement (see *Materials and Methods*) to allow neuronal differentiation (D0). After 2 d (D2), cells were treated with 10 μM cytosine β-[d]{.smallcaps}-arabino­furanoside hydrochloride (AraC). Cells were harvested on UD, D0, D2, D4, and D6. Total RNA was isolated and analyzed by RT-PCR using primers complementary to the indicated transcripts and isoforms as listed in Supplemental Table S1. Total cell lysate proteins were analyzed by immunoblotting using antibodies against RBM4 and GAPDH.](1676fig1){#F1}

We previously demonstrated that RBM4 binds preferentially to CU-rich elements ([@B18]). Therefore we selected a set of previously reported neuronal transcripts that exhibit a differentiation-associated change in splicing pattern and contain CU-rich sequences near regulated exons ([@B29]). We then examined their splicing patterns in P19 cells. All examined transcripts (CLCB, Smap1, Kif1b, PKM, and Numb) exhibited a splicing switch during P19 cell differentiation ([Figure 1](#F1){ref-type="fig"}). Kif1b is a direct target of RBM4 ([@B23]). Our result thus showed that the switch of Kif1bβ3 to Kif1bβ, which involves exon 25 inclusion, indeed correlated well with the up-regulation of RBM4 ([Figure 1](#F1){ref-type="fig"}). Among these genes, Numb is important for neuronal development ([@B31]; [@B1]). Mouse Numb isoform expression during neuronal development essentially involves differential selection of exon 3 (E3) and E9 ([@B1]). Induction of neuronal differentiation immediately resulted in E3 inclusion and E9 skipping (day 0), which coincided with the increase in total RBM4 protein ([Figure 1](#F1){ref-type="fig"}). We thus inferred that RBM4 might promote E3 inclusion and E9 skipping. Nevertheless, a splicing suppressor might counteract the effect of RBM4 on E3 at and after D2, resulting in E3 skipping ([Figure 1](#F1){ref-type="fig"}).

RBM4 modulates alternative splicing of Numb
-------------------------------------------

To evaluate whether RBM4 is involved in Numb pre-mRNA splicing, we attempted to deplete RBM4 in P19 cells using short hairpin RNA (shRNA) targeting RBM4 (shRBM4). We transfected cells with a vector expressing shRBM4. RBM4 protein level was reduced by ∼70% ([Figure 2A](#F2){ref-type="fig"}). Under this condition, both E3 inclusion and E9 skipping were suppressed (∼10 and ∼30%, respectively; [Figure 2A](#F2){ref-type="fig"}). In addition, we examined Numb isoform expression in *Rbm4a*-knockout mice. RNA was extracted from mouse whole brain at embryonic day 13.5 (E13.5) and subjected to reverse transcription-PCR (RT-PCR). The absence of Rbm4a mRNA confirmed *Rbm4a* knockout. Compared with wild-type littermates, E3 inclusion and E9 skipping were reduced by ∼30 and ∼20%, respectively, in *Rbm4a*-knockout embryonic brain ([Figure 2B](#F2){ref-type="fig"}). These data further suggested that RBM4 modulates Numb isoform expression.

![RBM4 knockdown impairs Numb exon selection and reduces Mash1 expression. (A) P19 cells were transfected with plasmid expressing RBM4-targeting shRNA (shRBM4) or luciferase-targeting shRNA (shLuc), followed by treatment with 1 μM RA for 2 d and subsequently in the neural basal medium for 2 d. RNA and protein were respectively analyzed by RT-PCR and immunoblotting using specific primers and antibodies as indicated. E3 inclusion (+E3) and E9 skipping (−E9) percentages were calculated by the ratio of +E3 (or −E9) to total in individual lanes (control was set as 100%). Relative Mash1 level is indicated. The averages and SEs were obtained from three independent experiments; the same applies hereafter. (B) Total RNA was isolated from E13.5 brain of Rbm4a-knockout and wild-type littermate embryos and analyzed by RT-PCR using gene specific primers. Splicing efficiency calculation was as in A. Relative Mash1, Hes1, and Hes5 levels were measured from three pairs of mouse embryos. The averages and SEs are indicted at the bottom of the individual gels; the wild type was set as 100%. (C) P19 cells were transiently transfected with the vector expressing shRBM4 (left) or FLAG-RBM4 (right); shLuc and empty vector were used as control in their respective transfections. RT-PCR, immunoblotting and calculations of Mash1, Hes1, and Hes5 levels were essentially as in B. RNA from the shRNA transfectants was also analyzed by quantitative RT-PCR; bar graph shows averages with SEs of three independent experiments.](1676fig2){#F2}

To confirm the effect of RBM4 on the utilization of both alternative exons of Numb, we generated Numb minigene reporters containing either E3 or E9 ([Figure 3A](#F3){ref-type="fig"}). Overexpression of human RBM4 promoted E3 inclusion in both P19 and HEK293T cells ([Figure 3B](#F3){ref-type="fig"}). RBM4 overexpression caused E9 skipping in P19 cells, but its effect was less apparent in HEK293T cells ([Figure 3B](#F3){ref-type="fig"}). We reasoned that the E9-skipped transcript predominated in HEK293T cells, so that its level could not be further enhanced by RBM4 overexpression. Finally, using immunoprecipitation and RT-PCR, we observed that RBM4 associated with the Numb transcript but not Mash1, which encodes a transcription factor essential for neural differentiation ([Figure 3C](#F3){ref-type="fig"}). Together these results suggest that RBM4 might directly regulate the selection of both functionally important exons of Numb.

![RBM4 regulates Numb E3 and E9 usage in a minigene assay. (A) Schematic representation of the Numb E3 and E9 minigene constructs. Primers used in RT-PCR (B) are indicated by arrows, and their sequences are listed in Supplemental Table S1. (B) The minigene assay was performed in P19 cells (left) and HEK293T cells (right). Cells were transiently transfected with the Numb E3 or E9 minigene plasmid and empty or RBM4 expression vector. Thirty hours posttransfection, total RNA was isolated and analyzed by RT-PCR. Relative E3 inclusion (+E3) and E9 skipping (−E9) efficiencies in P19 cells were calculated as in [Figure 2A](#F2){ref-type="fig"}. (C) Transfection of P19 cells was as in B. Cell lysates were subjected to immunoprecipitation using anti-FLAG M2 beads. Input and bound RNAs were analyzed by RT-PCR using primers complementary to Mash1 or Numb (spanning the region of E8 and the downstream intron; Supplemental Table S1). We used 2 and 5% of the inputs in RT-PCR and immunoblotting, respectively.](1676fig3){#F3}

RBM4 modulates the expression of neuronal differentiation genes
---------------------------------------------------------------

We next evaluated whether RBM4 also influences the expression of Notch target genes. Compared with the wild type, the levels of the *hairy* and *Enhancer-of-split* 1 (Hes1) mRNAs in E13.5 brain of *Rbm4*-deficint mice were not significantly altered, whereas the Hes5 mRNA level was increased by ∼50% ([Figure 2B](#F2){ref-type="fig"}). A similar result was observed in RBM4-knockdown P19 cells, in which Hes5 mRNA level was elevated but Hes1 remained essentially unchanged ([Figure 2C](#F2){ref-type="fig"}, left). Overexpression of RBM4 reduced the level of Hes5 by ∼60% in P19 cells, whereas the Hes1 level was only minimally changed ([Figure 2C](#F2){ref-type="fig"}, right). Therefore RBM4 had a more prominent effect on Hes5 expression and had little or no effect on Hes1.

We next examined the level of Mash1, a downstream target of Hes proteins ([@B14]). Mash1 mRNA level correlated with that of RBM4 protein level during P19 cell differentiation ([Figure 1](#F1){ref-type="fig"}) and was significantly down-regulated in RBM4-depleted P19 cells and *Rbm4a*-knockout brain ([Figure 2](#F2){ref-type="fig"}, A--C, left). The expression of Mash1 was up-regulated in P19 cells upon RBM4 overexpression ([Figure 2C](#F2){ref-type="fig"}, right), suggesting that RBM4 promotes Mash1 expression.

RBM4 modulates the expression of Mash1 via specific Numb isoforms
-----------------------------------------------------------------

Because Numb-PRR^S^ isoforms can induce Mash1 expression ([@B1]), we examined whether any Numb isoform could rescue Mash1 expression in RBM4-knockdown cells. We transfected P19 cells with the RBM4-targeting shRNA vector twice with a 2-d interval. We added an expression vector encoding FLAG-tagged RBM4 or each of the FLAG-tagged Numb isoforms ([Figure 4A](#F4){ref-type="fig"}) during the second transfection. Immunoblotting using anti-FLAG antibody showed appropriate expression of RBM4 and Numb isoforms in transfected cells ([Figure 4B](#F4){ref-type="fig"}, lane 3, RBM4; lanes 6--9, Numb isoforms). RT-PCR revealed that RBM4 could restore Mash1 expression (lane 3). Among Numb isoforms, the PRR^S^ isoforms, particularly Numb2, rescued Mash1 more efficiently (lanes 7 and 9), whereas Numb3 (PTB^S^-PRR^L^) failed (lane 8). Because RBM4 promoted E9 skipping and might thus increase the relative proportion of PRR^S^ isoforms, our results support a role for RBM4 in promoting Mash1 expression, perhaps via Numb-mediated pathways.

![Numb rescues Mash1 expression in RBM4-knockdown P19 cells in an isoform-specific manner. (A) Schematic of four Numb isoforms; the different lengths of the PTB and PRR domains result from differential usage of E3 and E9, respectively. (B) P19 cells were transfected by the shLuc or shRBM4 vector twice in a 2-d interval. At the second transfection, the mock vector (lanes 2 and 5) or the vector encoding FLAG-RBM4 (lane 3) or FLAG-Numb1-4 (lanes 6--9) was added. Cells were harvested 2 d after transfection. Total RNA was isolated for RT-PCR (Mash1 and GAPDH). Total protein was subjected to immunoblotting using anti--α-tubulin or anti-RBM4, which detected both endogenous and overexpressed RBM4. Right, bar graph showing quantitation of the RT-PCR signal intensities; average values were derived from three experiments. Statistical analysis between treatment groups was performed with Student's *t* test. \**p* \< 0.05.](1676fig4){#F4}

Overexpression of RBM4 promotes neuronal differentiation
--------------------------------------------------------

The result that RBM4 overexpression up-regulated Mash1 prompted us to evaluate whether RBM4 promotes neuronal differentiation. We used a neural stem/progenitor cell line, KT98, derived from transgenic mice with SV40 T-antigen--induced brain tumors bearing a stable green fluorescent protein transgene under the control of the brain-specific FGF1 promoter ([@B13]). We established a stable clone that could express FLAG-tagged RBM4 upon doxycycline induction and then selected GFP-positive cells with self-renewal and multipotency properties using fluorescence-activated cell sorting. Doxycycline treatment induced RBM4 expression ([Figure 5A](#F5){ref-type="fig"}). Under this condition, the level of Mash1 was elevated by ∼30%, consistent with that observed in P19 cells ([Figure 2C](#F2){ref-type="fig"}). On RBM4 induction, Numb E3 inclusion increased, albeit minimally (∼10%), but E9 skipping was not enhanced, possibly because it predominated in untreated cells ([Figure 5A](#F5){ref-type="fig"}). Furthermore, to examine whether RBM4 could promote neuronal differentiation, we cultured cells in medium containing growth factors to allow neurosphere formation, followed by differentiation. Doxycycline treatment increased neurite length by 50% ([Figure 5B](#F5){ref-type="fig"}), suggesting that RBM4 overexpression promoted neuronal differentiation.

![RBM4 enhances Mash1 expression and promotes differentiation of neuronal progenitor KT98 cells. (A) KT98-RBM4 cells that contained F1B-driven GFP and RBM4 transgene were cultured as described in *Materials and Methods*. RBM4 overexpression from the transgene was induced by 2 μg/ml doxycycline for 7 d. Total RNA was isolated from cells for RT-PCR. Mash1 and GAPDH were visualized by agarose gel electrophoresis; Numb isoforms were detected by Southern blotting using ^32^P-radiolabeled primers. Relative exon inclusion or exclusion efficiencies were calculated as in [Figure 2A](#F2){ref-type="fig"}. Bar graph shows quantitative RT-PCR of the level of Mash1 mRNA in mock- or doxycycline-treated cells from three experiments. (B) KT98-RBM4 cells were induced into neurospheres and followed by differentiation induction in medium containing B27 and growth factors (see *Materials and Methods*). Doxycycline (2 μg/ml) was added at the first day of differentiation induction. The averages of neurite length were measured from \>100 neurite-bearing cells. \**p* \< 0.05.](1676fig5){#F5}

RBM4 is involved in neurite outgrowth
-------------------------------------

Previous reports indicated that Numb also controls neurite outgrowth of neuroblastic PC-12 cells ([@B22]). *Rbm4a*^−*/*−^ cortical neurons exhibited poor neurite outgrowth compared with the wild type when cultured for a short period of time (Supplemental Figure S2). We therefore examined whether Numb isoform expression changed during neuronal cell development. We isolated cortical neurons from E18.5 rat embryos and subjected them to in vitro culture for up to 9 d. MAP2 expression increased throughout the culture period ([Figure 6A](#F6){ref-type="fig"}). Although Rbm4 mRNAs were up-regulated, total RBM4 protein level did not increase ([Figure 6A](#F6){ref-type="fig"}). We observed a gradual increase in E3 inclusion and E9 skipping of Numb ([Figure 6A](#F6){ref-type="fig"}). To test whether RBM4 is involved in neurite elongation, we cotransfected the expression vectors for shRBM4 and GFP into cortical neurons at DIV1. Using GFP as indicator of shRNA transfection, we observed that the neurite length of RBM4-knockdown neurons was reduced by ∼40% compared with mock-treated cells at DIV3 ([Figure 6B](#F6){ref-type="fig"}). Next we cotransfected an RBM4 or Numb isoform expression vector with the shRNA and GFP vectors and found that RBM4 and either of the PRR^S^ isoforms (Numb2 or 4) could rescue neurite outgrowth of RBM4-depleted cortical neurons ([Figure 6B](#F6){ref-type="fig"}). The activity of the PRR^S^ isoforms in neurite elongation was coincident with E9 skipping, which prevailed at later stages of neuronal development ([Figures 1](#F1){ref-type="fig"} and [6](#F6){ref-type="fig"}). Therefore our data suggested that RBM4 may regulate Numb isoform expression, which in turn influences downstream pathways linked to neurite outgrowth.

![RBM4-induced Numb isoforms restore neurite outgrowth in RBM4-depleted cortical neurons. (A) Cortical neurons from E18.5 rat embryos were cultured in vitro and harvested at DIV1, 5, and 9. RNA and protein were separately isolated for RT-PCR and immunoblotting analysis. (B) The shLuc or shRBM4 expression vector was cotransfected with either the FLAG-RBM4 or FLAG-Numb expression vector at DIV1, and images were collected at DIV3. Representative images. Bar graph shows the number of neurite-bearing cells from four selected fields; \>100 cells were quantified. \**p* \< 0.05.](1676fig6){#F6}

DISCUSSION
==========

The present study shows for the first time that a single pre-mRNA splicing regulator, RBM4, contributes to the selection of two alternative exons of Numb. RBM4-mediated Numb isoform expression is important for neuronal differentiation and neurite outgrowth.

RBM4 regulates alternative splicing of Numb
-------------------------------------------

Numb was initially identified as a Notch antagonist, and its many other functions were discovered later ([@B12]). For example, Numb plays a role in membrane trafficking via association with clathrin, and it also regulates actin dynamics ([@B12]). In neurons, Numb is critical for neurogenesis and can also regulate neurite outgrowth and synapse formation of mature neurons ([@B26]; [@B22]). However, the biochemical properties and biological functions of each Numb isoform have not been completely and clearly assigned. Neuronal differentiation involves differential selection of E3 and E9, whereas E9 inclusion has been implicated in cancer progression ([@B2]; [@B15]; [@B35]). RBM4 is the first splicing factor shown to determine E3 selection. RBM4 regulates exon selection generally by binding CU-rich elements ([@B18]). However, deletion or mutation of several CU-rich motifs near Numb E3 did not affect RBM4-mediated exon selection (unpublished data). In addition, RBM4 suppresses E9 inclusion, as reported for several other splicing regulators ([@B2]; [@B15]; [@B35]). Rbfox3 and RBM10 bind to intronic sequences immediately upstream of E9, whereas QKI-5 binds to E9 to prevent the core splicing factor SF1 from binding to the branch-site sequence of the upstream intron ([@B2]; [@B15]; [@B35]). Although we found that RBM4 associates with Numb transcripts ([Figure 3](#F3){ref-type="fig"}), its exact binding site(s) are still to be determined. Our present results imply a role for RBM4-mediated Numb isoform expression in neuronal cell differentiation. It is also worth noting that RBM4-mediated suppression of Numb E9 inclusion may contribute to tumor suppression ([@B2]; [@B35]). Thus further exploration of the mechanism underlying RBM4-mediated splicing regulation of Numb is warranted.

Potential role for RBM4 in regulating Notch signaling
-----------------------------------------------------

RBM4-regulated Numb splicing may possibly influence cellular Notch signaling activity. Notch signaling activates the expression of Hes1/5 and subsequently leads to Mash1 suppression during neurogenesis ([@B14]). The Numb-Notch signaling pathway controls asymmetric division during neural development of *Drosophila*, whereas mammalian Notch functions to maintain neural stem cells and determine specific cell fates ([@B9]). Moreover, mammalian Numb generates isoforms with differential activities in modulating Notch protein processing. Numb-PTB^S^ isoforms are relatively weak inhibitors of Notch ([@B1]). Notch activation--induced Hes1/5 expression suppresses Mash1 and another neuronal transcription factor, neurogenin 2 ([@B14]). We observed that *Rbm4a* knockout or RBM4 depletion increased Hes5 level, and RBM4 overexpression reduced Hes5 ([Figure 2](#F2){ref-type="fig"}). However, the effect of RBM4 on Hes1 was negligible. We assumed that this is because Hes1 expression oscillates through negative feedback ([@B14]), so that we might have been unable to detect a significant change in Hes1 expression in our experimental assessment. Nevertheless, RBM4 knockdown and overexpression, respectively, suppressed and induced Mash1 in P19 cells ([Figure 2](#F2){ref-type="fig"}). RBM4 overexpression also induced Mash1 in KT98 cells ([Figure 5](#F5){ref-type="fig"}), confirming a close correlation between RBM4 and Mash1 expression. Moreover, we observed that RBM4-induced Numb isoforms exhibited a higher potential for induction of Mash1 expression and neurite outgrowth ([Figures 4](#F4){ref-type="fig"} and [6](#F6){ref-type="fig"}), which is consistent with the ability of Numb-PRR^S^ to promote Mash1 expre­ssion and neuronal differentiation ([@B1]). Nevertheless, why RBM4 has a differential effect on Hes1/5 expression ([Figure 2](#F2){ref-type="fig"}) remains to be answered. Together our results suggest that RBM4 modulates Mash1 expression via the Numb-Notch-Hes pathway, but at present we cannot exclude other possible mechanisms.

Roles of RBM4 in neuronal differentiation and neurite outgrowth
---------------------------------------------------------------

Numb isoforms have overlapping but distinct roles in neuronal differentiation ([@B31]; [@B1]). It is not fully clear how individual isoforms function and how the balance between these isoforms is developmentally regulated. E3 was included in RA-induced embryo bodies but subsequently skipped upon induction of differentiation ([Figure 1](#F1){ref-type="fig"}). Such transient inclusion of E3 in Numb (PTB^L^) causes Notch inhibition and thereby initiates neuronal differentiation ([@B14]). Although RBM4 overexpression or depletion affected Numb isoform expression to different extents in different cell types, RBM4-induced E3 inclusion might contribute to Mash1 expression---a possible consequence of Notch inhibition---at early differentiation stages. Indeed, we observed that RBM4-induced Numb2 (PTB^L^-PRR^S^) had a greater ability to restore Mash1 expression in RBM4-depleted cells ([Figure 4](#F4){ref-type="fig"}). Therefore RBM4 induces Mash1 expression, at least in part, by regulating the Numb isoform switch, which subsequently promotes neuronal differentiation. However, the possibility remains that RBM4-induced Mash1 results from combined effects of different pathways and is influenced by different cellular contexts.

Notch and Numb are also involved in neurite outgrowth. Numb may function by modulating Notch activity ([@B3]) or endocytosis and recycling at the growth cone via its association with neuronal cell adhesion factors ([@B26]). Indeed, Numb-PTB^S^ isoforms promote neurite outgrowth in response to neurotrophic factors or neuronal activation ([@B22]). However, our observation that Numb2 and Numb4 reversed neurite outgrowth in RBM4-depleted neurons ([Figure 6](#F6){ref-type="fig"}) suggests that the PRR domain may determine neurite outgrowth during cell differentiation. This result coincides with the observed gradual and perhaps irreversible E9 skipping during neuronal differentiation and maturation ([Figures 1](#F1){ref-type="fig"} and [6](#F6){ref-type="fig"}). Together our in vitro data suggest that specific Numb isoforms are involved in RBM4-mediated neuronal differentiation and neurite outgrowth. However, whether RBM4-regulated Numb isoforms modulate neurite outgrowth by inhibiting Notch activity or via Notch-independent pathways remains to be answered.

Future studies need to clarify how splicing factors collectively regulate the balance between various Numb isoforms and how Numb isoforms coordinately function in neural development.

MATERIALS AND METHODS
=====================

Plasmids
--------

The expression vectors for FLAG-tagged human and mouse RBM4a and RBM4 mutant have been described ([@B23]). Plasmid pAS4.1w-hRBM4-IRES-RFP-Ppuro-aOn was constructed by inserting the open reading frame encoding human RBM4 (hRBM4) and the fragment IRES-RFP (internal ribosome entry site followed by red fluorescent protein, derived from pTagRFP-N; Evrogen, Moscow, Russia) into the multiple cloning sites of vector pAS4.1w-Ppuro-aOn, which was purchased from the National RNAi Core Facility, Academia Sinica. The shRNA vectors for targeting RBM4 (pLKO.1-shRBM4-puro) or luciferase (as control; pLKO.1-shLuc-puro) were also purchased from the National RNAi Core Facility. The plasmids expressing four Numb isoforms ([@B31]) were constructed by inserting each of the FLAG-tagged Numb isoforms into vector pcDNA3.1: Numb1 (PTB^L^PRR^L^), Numb2 (PTB^L^PRR^S^), Numb3 (PTB^S^PRR^L^), and Numb4 (PTB^S^PRR^S^).

To construct the mouse Numb E3 and E9 minigenes, the PCR-amplified DNA fragments as follows were ligated and inserted into vector pCH110. The Numb-E3 minigene contained a 375--base pair exon 2--intron fragment (nucleotides \[nt\] 83831622--83831996 of chromosome 12, genome assembly GRCm38.p3, accession number NC_000078.6), a 633--base pair intron--exon 3--intron fragment (nt 83824959--83825591), and a 375--base pair intron--exon 4 fragment (nt 83811286--83811660). The Numb-E9 minigene contained a 450--base pair exon--intron 8 fragment (nt 83799208--83799657), a 747--base pair intron--exon 9--intron fragment (nt 83796897-83797643), and a 550--base pair intron--exon 10 fragment (nt 83795905--83796454).

RNA extraction from embryonic mouse brain
-----------------------------------------

Total RNA from E13.5 *Rbm4a* knockout ([@B20]) and wild-type littermate brains was extracted using TRIzol reagent (Life Technologies, Carlsbad, CA) following manufacturer's instructions and used for RT-PCR.

Culture and neuronal differentiation of P19 cells
-------------------------------------------------

The mouse embryonal carcinoma cell line P19 was maintained in DMEM supplemented with 7.5% newborn calf serum, 2.5% fetal bovine serum (FBS), 2 mM [l]{.smallcaps}-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (all from Life Technologies).

For differentiation of P19 cells, 2 × 10^6^ cells/ml were first suspension cultured in bacterial-grade dishes containing the differentiation medium to induce embryoid body formation; the differentiation medium was composed of DMEM, 3.75% FBS, 1.25% newborn calf serum, a mixture of penicillin, streptomycin, and [l]{.smallcaps}-glutamine (as described), and 1 μM all-*trans* RA (Sigma-Aldrich, St. Louis, MO). Subsequently, 1 × 10^6^ cells were placed in neurobasal medium (Life Technologies) containing B27 supplement minus vitamin A (Life Technologies) and 10 μM DNA synthesis inhibitor cytosine β-[d]{.smallcaps}-arabinofuranoside hydrochloride (Sigma-Aldrich). The medium was replaced every 2 d during the induction of cell differentiation.

Culture and neuronal differentiation of KT98 cells
--------------------------------------------------

KT98 cells derived from F1B-Tag transgenic mouse line 98 ([@B13]) were maintained in DMEM/F12 (Life Technologies) supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. F1B-driven GFP expression was used as an indicator for isolating a population of KT98 cells with higher self-renewal and multipotent capacities ([@B13]). To establish stable clones for inducible expression of RBM4 (KT98-RBM4), GFP-positive KT98 cells were transfected with plasmid pAS4.1w-hRBM4-IRES-RFP-Ppuro-aOn. Transfectants were selected with 3 μg/ml puromycin (Sigma-Aldrich) for 4 d, followed by induction with 2 μg/ml doxycycline (Sigma-Aldrich) for 7 d. GFP and RFP double-positive KT98 cells were sorted using a FACSAria III flow cytometer (BD Biosciences, Franklin Lakes, NJ) each week for 4 wk.

For neuronal differentiation of KT98-RBM4 cells, neurospheres were initially induced in DMEM/F12 supplemented with B27, 20 ng/ml epidermal growth factor (EGF), 20 ng/ml fibroblast growth factor 2 (FGF2), and 2 μg/ml heparin for 7 d, followed by culture in DMEM/F12 containing 2% FBS, 10 ng/ml platelet-derived growth factor (PDGF), 50 ng/ml brain-derived neurotrophic factor (BDNF), and 50 ng/ml glial cell--derived neurotrophic factor for 7--9 d ([@B13]). Differentiated cells were verified as described ([@B13]).

Primary rat cortical neuron culture
-----------------------------------

Cortical neurons were isolated from rat embryos (E18.5) and seeded at 1 × 10^5^ cells/well in 24-well plates with coverslips that had been precoated with 1 mg/ml poly-[d]{.smallcaps}-lysine (Merck Millipore, Billerica, MA). Cells were cultured in the neurobasal medium containing 2% B27, 0.5 mM [l]{.smallcaps}-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. Neurons were transfected with the RBM4-targeting shRNA (shRBM4) vector alone or together with the human RBM4 or mouse Numb expression vector. Morphological analysis of neuronal cells was carried out as described ([@B7]).

Splicing assays
---------------

In general, 2 × 10^5^ P19 or HEK293T cells were seeded in each well of a six-well plate 1 d before transfection, followed by 2 or 4 μg of pcDNA-FLAG hRBM4 overexpression plasmid or shRNA-expressing plasmids using Lipofectamine 2000 (Life Technologies) according to manufacturer's instructions. For minigene reporter assays, cells were cotransfected with 0.5 or 1 μg of E3 or E9 minigene vector. Transfected cells were harvested at 30 h posttransfection. Total RNA was extracted, followed by RT-PCR.

RT-PCR and immunoprecipitation
------------------------------

For RT-PCR, 2 μg of total RNA was treated with RQ1 DNase (Promega, Madison, WI), followed by RT using oligo d(T) primer and the SuperScript III kit (Life Technologies). The resulting cDNA was then analyzed by PCR using corresponding specific primers. RT-PCR products were visualized by agarose gel electrophoresis or further detected with Southern blotting using ^32^P-labeled primers as described ([@B18]). Band intensities were analyzed using ImageJ, 1.47 version ([imagej.nih.gov/ij](http://imagej.nih.gov/ij)). Quantitative RT-PCR was performed using the SensiFAST SYBR No-ROX kit (Bioline, Taunton, MA) according to the manufacturer's instructions. Supplemental Table S1 lists the primers used.

For immunoprecipitation, 2 × 10^6^ P19 cells were transfected for 2 d with 24 μg of the pcDNA-flag-hRBM4a or control plasmid as described. After harvest, cells were lysed in hypotonic lysis buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 10 mM EDTA, 0.5% Triton X-100) containing protease inhibitor cocktail (Roche, Indianapolis, IN), followed by immunoprecipitation using anti-FLAG M2 beads as described ([@B20]). RNA was subjected to RT-PCR using primers specific to mouse Numb exon 8 (Supplemental Table S1).

Immunoblotting
--------------

Immunoblotting was performed as described ([@B18]). We used affinity-purified polyclonal antibodies against RBM4 ([@B18]), α-tubulin (GenScript, Piscataway, NJ), glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Proteintech, Rosemont, IL), and FLAG (Sigma-Aldrich).

Statistical analysis
--------------------

The Student's *t*-test was performed to determine the significance of differences between treatment groups in [Figures 4--6](#F4 F5 F6){ref-type="fig"}. Error bars represent SEM. *p* \< 0.05 was considered statistically significant.
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AraC

:   cytosine β-[d]{.smallcaps}-arabinofuranoside hydrochloride

BDNF

:   brain-derived neurotrophic factor

EGF

:   epidermal growth factor

FGF2

:   fibroblast growth factor 2

PDGF

:   platelet-derived growth factor

RA

:   retinoic acid.
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